Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the promotion of Sam Brinkley to Partner.

“Since joining Amulet, Sam has been an important member of our investment team and has worked closely with our partner / portfolio companies to drive key growth and operational priorities,” said Ramsey Frank, CEO of Amulet. “His partnership mindset, disciplined execution, and deep understanding of healthcare businesses reflect how we approach investing and value creation.”

“Sam has been closely involved in Amulet’s investments in fertility and reproductive health, an area where we have deep experience and continue to see compelling opportunity,” said Jay Rose, President of Amulet. “He has helped navigate complex situations and worked closely with management teams to build and scale businesses grounded in clinical excellence, physician alignment, and operational execution. We look forward to his continued leadership as a Partner.”

Mr. Brinkley joined Amulet in 2020 as a Vice President and was promoted to Principal in 2024. Since joining the firm, he has played a leading role in numerous investments across Amulet’s portfolio, including US Fertility, Genetics & IVF Institute, and TFP Fertility Group. He has also played a critical role supporting the firm’s strategic initiatives and efforts across the investment lifecycle, from sourcing and evaluating opportunities to executing transactions and working alongside management teams on long-term strategic priorities.

“Over the past six years, I have had the opportunity to work alongside exceptional colleagues and experienced management teams to help develop and grow businesses in complex – but critical – areas of the healthcare market,” said Mr. Brinkley. “I have been particularly proud of our work in fertility and reproductive health, where supporting strong clinical leadership and expanding access to high-quality care go hand in hand. Together with Ramsey, Jay, and the entire team, I look forward to building on our momentum as a firm and across the portfolio.”

Before joining Amulet, Mr. Brinkley was an Investment Associate with The Riverside Company. Earlier in his career, he worked at BlackArch Partners, a middle-market investment bank primarily focused on sell-side mergers and acquisitions. Mr. Brinkley holds an M.B.A., with honors, from the University of Chicago Booth School of Business and a B.A., with honors, in economics from Williams College.

About Amulet Capital Partners

Amulet Capital Partners is a middle-market private equity investment firm based in Greenwich, CT, and Walnut Creek, CA, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in healthcare companies, focusing on those segments it believes have the most attractive long-term fundamentals. Amulet currently manages approximately $3.8 billion of Regulatory Assets Under Management (as of September 4, 2026) and is investing out of its third fund. For additional information, please visit www.amuletcapital.com.

Media gallery

About The Author
Business Wire